Remus Pharmaceuticals
₹7,948.3
+108.3 (1.38%)
18 May, 2024 18:05 BSE:
NSE: REMUSISIN: INE0O5T01011
Start SIP in Remus Pharmaceuticals
Start SIPRemus Pharmaceuticals Performance
Day Range
- Low 7,850
- High 7,989
52 Week Range
- Low 1,711
- High 8,747
- Open Price7,920
- Previous Close7,840
- Volume550
Remus Pharmaceuticals Financials
| Indicator | Mar 2023 |
|---|---|
| Total Revenue Annual Cr | 47 |
| Operating Expenses Annual Cr | 34 |
| Operating Profit Annual in Cr | 11 |
| Depreciation Cr | 0 |
| Interest Annual Cr | 0 |
| Tax Annual Cr | 3 |
| Net Profit Annual Cr | 9 |
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹7,948.3
+108.3 (1.38%)
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹7,437.33
- 50 Day
- ₹6,937.46
- 100 Day
- ₹6,514.25
- 200 Day
- ₹5,676.81
- 20 Day
- ₹7,566.48
- 50 Day
- ₹6,586.04
- 100 Day
- ₹6,659.48
- 200 Day
- ₹5,841.97
Remus Pharmaceuticals Resistance and Support
PIVOT
₹7,929.1
| Resistance | |
|---|---|
| First Resistance | 8,008.20 |
| Second Resistance | 8,068.10 |
| Third Resistance | 8,147.20 |
| RSI | 59.35 |
| MFI | 68.43 |
| MACD Single Line | 342.00 |
| MACD | 346.50 |
| Support | |
|---|---|
| First Support | 7,869.20 |
| Second Support | 7,790.10 |
| Third Supoort | 7,730.20 |
Remus Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 4,750 | 315,020 | 66.32 |
| Week | 6,565 | 402,500 | 61.31 |
| 1 Month | 6,060 | 359,390 | 59.31 |
| 6 Month | 2,803 | 186,392 | 66.49 |
Remus Pharmaceuticals Result Highlights
Remus Pharmaceuticals Synopsis
NSE-Medical-Whlsle Drg/Suppl
Remus Pharmaceutic belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 45.03 Cr. and Equity Capital is Rs. 1.09 Cr. for the Year ended 31/03/2023. Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536.| Market Cap | 1,155 |
| Sales | 45 |
| Shares in Float | 0.04 |
| No of funds | 3 |
| Yield | 0.08 |
| Book Value | 44.45 |
| U/D Vol ratio | 1.1 |
| LTDebt / Equity | 37 |
| Alpha | 0.52 |
| Beta | 1.49 |
Remus Pharmaceuticals Shareholding Pattern
| Owner Name | Mar-24 | Sep-23 |
|---|---|---|
| Promoters | 70.6% | 69.61% |
| Foreign Portfolio Investors | 3.25% | 2.38% |
| Individual Investors | 20.54% | 21.15% |
| Others | 5.61% | 6.86% |
Remus Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Swapnil Jatinbhai Shah | Chairman & Wholetime Director |
| Mr. Arpit Deepakkumar Shah | Managing Director |
| Mrs. Anar Swapnil Shah | Whole Time Director |
| Ms. Roma Vinodbhai Shah | Whole Time Director |
| Mr. Balwant Purohit | Independent Director |
| Mrs. Sanjana Sanjeev Shah | Independent Director |
| Mr. Vishrut Chandramauli Pathak | Independent Director |
Remus Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Remus Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-04-23 | Bonus issue & Interim Dividend | |
| 2024-04-22 | Interim Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-02 | INTERIM | Rs.0.00 2nd interim dividend of Rs. 4.00/- (Rupees Four only) per equity share having face value of Rs. 10/- each for the financial year 2023-24. |
| 2023-10-28 | INTERIM | Rs.0.00 Interim Dividend of Rs. 2 per equity share. |
Remus Pharmaceuticals FAQs
What is Share Price of Remus Pharmaceuticals ?
Remus Pharmaceuticals share price is ₹7,948 As on 18 May, 2024 | 17:51
What is the Market Cap of Remus Pharmaceuticals ?
The Market Cap of Remus Pharmaceuticals is ₹1170.8 Cr As on 18 May, 2024 | 17:51
What is the P/E ratio of Remus Pharmaceuticals ?
The P/E ratio of Remus Pharmaceuticals is As on 18 May, 2024 | 17:51
What is the PB ratio of Remus Pharmaceuticals ?
The PB ratio of Remus Pharmaceuticals is 61.2 As on 18 May, 2024 | 17:51